Skip to main content
. 2020 Apr 28;2(2):100027. doi: 10.1016/j.cytox.2020.100027

Table 6.

Summary of platform performance across the five technology platforms based on precision and FEAD in the plasma samples from the clinical populations and healthy controls.

graphic file with name fx1.gif

*Assay Performance was ranked as follows:

High: Precision, CV ≤ 20%; FEAD (BLQ%) < 50%.

Intermediate: Precision, CV 20–75%; FEAD (BLQ%) 50–75%.

Low: Precision, CV > 75%; FEAD (BLQ%) > 75%.